Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

2425.86 (Glytoucan)

Id:8e2ba611-0542-5680-976c-3a55ed5f320f

Glytoucan:G73510JF

Results found

Linked to

	Label	Description
	2425.86 has glycosequence GLYGEN.GLYCOSEQUENCE:G20266PH-GLYCOSEQ00055978 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2425.86 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000018 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2425.86 has motif Type 2 LN2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2425.86 has glycosequence GLYGEN.GLYCOSEQUENCE:G83508KY-GLYCOSEQ00030938 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2425.86 has glycosequence GLYGEN.GLYCOSEQUENCE:G50779LX-GLYCOSEQ00011262 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2425.86 has glycosequence GLYGEN.GLYCOSEQUENCE:G35465JY-GLYCOSEQ00173349 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2425.86 has glycosequence GLYGEN.GLYCOSEQUENCE:G83508KY-GLYCOSEQ00030937 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2425.86 has glycosequence GLYGEN.GLYCOSEQUENCE:G89799OK-GLYCOSEQ00016975 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2425.86 has glycosequence GLYGEN.GLYCOSEQUENCE:G84494PZ-GLYCOSEQ00164078 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2425.86 has glycosequence GLYGEN.GLYCOSEQUENCE:G20746DT-GLYCOSEQ00086569 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2425.86 has glycosequence GLYGEN.GLYCOSEQUENCE:G20266PH-GLYCOSEQ00055978 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2425.86 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000018 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2425.86 has motif Type 2 LN2

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2425.86 has glycosequence GLYGEN.GLYCOSEQUENCE:G83508KY-GLYCOSEQ00030938 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2425.86 has glycosequence GLYGEN.GLYCOSEQUENCE:G50779LX-GLYCOSEQ00011262 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2425.86 has glycosequence GLYGEN.GLYCOSEQUENCE:G35465JY-GLYCOSEQ00173349 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2425.86 has glycosequence GLYGEN.GLYCOSEQUENCE:G83508KY-GLYCOSEQ00030937 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2425.86 has glycosequence GLYGEN.GLYCOSEQUENCE:G89799OK-GLYCOSEQ00016975 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2425.86 has glycosequence GLYGEN.GLYCOSEQUENCE:G84494PZ-GLYCOSEQ00164078 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2425.86 has glycosequence GLYGEN.GLYCOSEQUENCE:G20746DT-GLYCOSEQ00086569 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.